I agree that this site is using cookies. You can find further informations here.
X
Descourt, Renaud
81  results:
Search for persons X
?
1

Incidence of venous thromboembolism and association with PD..:

Aguiar De Azevedo, Liliana ; Orione, Charles ; Tromeur, Cécile...
Frontiers in Oncology.  13 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
2

Real-life clinical management patterns in extensive-stage s..:

Mennecier, Bertrand ; Khalifa, Jonathan ; Descourt, Renaud...
BMC Cancer.  24 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
3

Uncommon MET mutational landscape in a non-small cell lung ..:

Geier, Margaux ; Nguyen, Jessica ; Dhamelincourt, Estelle...
Heliyon.  10 (2024)  11 - p. e31944 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Real-World Treatment Outcomes of MET Exon14 Skipping in Non..:

Babey, Hélène ; Jamme, Philippe ; Curcio, Hubert...
Targeted Oncology.  18 (2023)  4 - p. 585-591 , 2023
Link: https://doi.org/10.1007/..
 
?
5

Clinical Characteristics of Patients with Advanced ALK-Tran..:

Dhamelincourt, Estelle ; Descourt, Renaud ; Rousseau-Bussac, Gaelle...
Targeted Oncology.  18 (2023)  6 - p. 905-914 , 2023
Link: https://doi.org/10.1007/..
 
?
6

Case Report: Coronaro-bronchial fistula vascularizing a squ..:

Ntshaykolo, Chloe ; Fave, Thomas ; Benic, Clement...
Frontiers in Cardiovascular Medicine.  10 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
7

Venous thrombotic events and impact on outcomes in patients..:

Doubre, Hélène ; Greillier, Laurent ; Justeau, Grégoire...
Journal of Cancer Research and Clinical Oncology.  149 (2023)  16 - p. 15095-15102 , 2023
Link: https://doi.org/10.1007/..
 
?
8

Brief Report: First-line Pembrolizumab in Metastatic Non-Sm..:

Guisier, Florian ; Descourt, Renaud ; Babey, Helene...
Clinical Lung Cancer.  23 (2022)  8 - p. e545-e549 , 2022
Link: https://doi.org/10.1016/..
 
?
9

First-line single-agent pembrolizumab for PD-L1-positive (t..:

Descourt, Renaud ; Greillier, Laurent ; Perol, Maurice...
Cancer Immunology, Immunotherapy.  72 (2022)  1 - p. 91-99 , 2022
Link: https://doi.org/10.1007/..
 
?
10

Lorlatinib for advanced anaplastic lymphoma kinase–positive..:

Baldacci, Simon ; Besse, Benjamin ; Avrillon, Virginie...
European Journal of Cancer.  166 (2022)  - p. 51-59 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Paclitaxel–bevacizumab combination in advanced non-squamous..:

Bilger, Geoffroy ; Toffart, Anne-Claire ; Darrason, Marie...
Therapeutic Advances in Medical Oncology.  14 (2022)  - p. 175883592210993 , 2022
Link: https://doi.org/10.1177/..
 
?
12

Brigatinib for Pretreated, ALK-Positive, Advanced Non-Small..:

Descourt, Renaud ; Pérol, Maurice ; Rousseau-Bussac, Gaëlle...
Cancers.  14 (2022)  7 - p. 1751 , 2022
Link: https://doi.org/10.3390/..
 
?
13

Real‐life second‐line epirubicin–paclitaxel regimen as trea..:

Annic, Josselin ; Babey, Hélène ; Corre, Romain...
Cancer Medicine.  12 (2022)  3 - p. 2658-2665 , 2022
Link: https://doi.org/10.1002/..
 
?
14

Impact of KRAS G12C mutation in patients with advanced non-..:

Justeau, Grégoire ; Huchot, Eric ; Simonneau, Yannick...
Lung Cancer.  174 (2022)  - p. 45-49 , 2022
Link: https://doi.org/10.1016/..
 
?
15

Durvalumab‐induced lesions of bronchiolitis and fully rever..:

Domblides, Maël ; Geier, Margaux ; Decroisette, Chantal.
Thoracic Cancer.  12 (2021)  8 - p. 1240-1243 , 2021
Link: https://doi.org/10.1111/..
 
1-15